trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['mbc', 'breast']
today a practice changing diagnosis and treatment in breast cancer was presented at #asco22. her2 low a new bc entity and t-dxd a drug that improved pfs and os. a new hope for mbc patients. 
Medical Oncologist, Breast Cancer Program at Hospital Moinhos de Vento, Clinical Investigator at Hospital São Lucas @PUCRS, Chair @Lacog_group